Summaries & Associations of Study Results
TR-332 2-Mercaptobenzo-Thiazole
Target Organs and Levels of Evidence
NTP Technical Report Number 332
Produced from Chemtrack Database 09/19/01
CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
---|---|---|---|---|
2-MERCAPTOBENZOTHIAZOLE 149-30-4 |
03/04/87 | RUBBER VULCANIZATION ACCELERATOR. SALTS USED AS FUNGICIDE. CORROSION INHIBITOR FOR COPPER IN AQUEOUS SYSTEMS,CUTTING OILS AND PETROLEUM PRODUCTS. ADDITIVE IN EXTREME-PRESSURE GREASES. (TDB) | Gavage FR: 0,188,375, MR&M: 0,375,750 MG/KG/50 PER GROUP | Physiological Research Laboratory |
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
MR: SOME EVIDENCE | HEMATOPOIETIC SYSTEM: LEUKEMIA 7/50 16/50 3/50 | |||
PANCREAS ACINAR CELL: ADENOMA 2/50 13/50 6/50 | ||||
ADRENAL GLAND MEDULLA: PHEOCHROMOCYTOMA 18/50 25/50 22/49 OR MALIGNANT PHEOCHROMOCYTOMA 0/50 2/50 2/49 COMBINED 18/50 27/50 24/49 | ||||
PREPUTIAL GLAND: ADENOMA 0/50 4/50 4/50 OR CARCINOMA 1/50 2/50 1/50 COMBINED 1/50 6/50 5/50 | ||||
FR: SOME EVIDENCE | ADRENAL GLAND MEDULLA: PHEOCHROMOCYTOMA 1/50 5/50 6/50 | |||
PITUITARY GLAND: ADENOMA 15/49 24/50 25/50 | ||||
MM: NO EVIDENCE | ||||
FM: EQUIVOCAL EVIDENCE | LIVER: ADENOMA 3/50 7/49 4/50 OR CARCINOMA 1/50 5/49 0/50 COMBINED 4/50 12/49 4/50 |
Web page last updated on February 10, 2006